P
Paul Angulo
Researcher at University of Kentucky
Publications - 193
Citations - 35512
Paul Angulo is an academic researcher from University of Kentucky. The author has contributed to research in topics: Nonalcoholic fatty liver disease & Primary sclerosing cholangitis. The author has an hindex of 77, co-authored 191 publications receiving 32339 citations. Previous affiliations of Paul Angulo include Mayo Clinic & Durham University.
Papers
More filters
Journal ArticleDOI
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Paul Angulo,Roberta A. Jorgensen,Jill C. Keach,E. Rolland Dickson,Coleman Smith,Keith D. Lindor +5 more
TL;DR: Oral budesonide appears to add minimal, if any, additional benefit to UDCA, and it is associated with a significant worsening of osteoporosis in patients with PBC.
Journal ArticleDOI
Is there a role for liver biopsy in primary sclerosing cholangitis
TL;DR: Liver biopsies rarely contribute new information that affects the management of patients with PSC, and given the risks of the procedure, liver biopsy for patients with a diagnosis of PSC established by cholangiography may not routinely be necessary.
Journal ArticleDOI
Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.
TL;DR: Increased serum concentrations of free fatty acids were found in NASH and were associated with development of more severe liver disease and neither choline deficiency nor celiac sprue by anti-endomysial antibody testing was associated with NASH.
Journal ArticleDOI
Bone disease in primary biliary cirrhosis: Independent indicators and rate of progression
TL;DR: S Severity of the liver disease contributes significantly to the severity of bone disease in PBC patients who are older, thinner and have more advanced liver disease may have the most benefit from bone density measurements and treatment for their osteoporosis.
Journal ArticleDOI
Liver Transplantation for the Treatment of Liver Metastases From Neuroendocrine Tumors: An Analysis of the UNOS Database
Roberto Gedaly,Michael F. Daily,Daniel L. Davenport,Patrick P. McHugh,Alvaro Koch,Paul Angulo,Jonathan Hundley +6 more
TL;DR: Patients with liver metastases from NETs who were undergoing LT had long-term survival similar to that of patients with hepatocellular carcinoma, and longer wait times were associated with better outcomes in this series.